{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:36:25Z","timestamp":1781663785800,"version":"3.54.5"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Lymphadenopathy with increased immunoglobulin (Ig) G4<jats:sup>+<\/jats:sup> plasma cells can be a nonspecific finding or a manifestation of immunoglobulin G4\u2013related disease (IgG4-RD). It remains unclear whether there are characteristic pathologic features of IgG4-RD involving lymph nodes, or if IgG4-RD lymphadenopathy can occur without other manifestations of IgG4-RD. In this study, we assessed 55 lymph node biopsy specimens (44 men and 11 women with a mean age of 55\u00a0y) with increased IgG4<jats:sup>+<\/jats:sup> plasma cells that had 1 of the 6 well-described pathologic patterns. We also correlated these findings with IgG4 serum levels and followed these patients for 7 to 108 months (mean, 34.9\u00a0mo) for the occurrence of extranodal IgG4-RD. We further compared lymphadenopathy in patients who developed other manifestations of IgG4-RD (RD<jats:sup>+<\/jats:sup>, n=20, 36%) versus those who did not (RD<jats:sup>\u2212<\/jats:sup>, n=35, 64%). We found that there were only minor significant differences between 2 groups, including frequency of receiving treatment (RD<jats:sup>+<\/jats:sup>, 90% vs. RD<jats:sup>\u2212<\/jats:sup>, 60%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.021) and higher serum levels of C-reactive protein (&gt;8\u00a0mg\/L, RD<jats:sup>+<\/jats:sup>, 53% vs. RD<jats:sup>\u2212<\/jats:sup>, 13%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.007). Other differences were either borderline or not significant, including mean age (RD<jats:sup>+<\/jats:sup>, 59.8\u00a0y vs. RD<jats:sup>\u2212<\/jats:sup>, 51.9\u00a0y, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.097), male-to-female ratio (RD<jats:sup>+<\/jats:sup>, 16:4 vs. RD<jats:sup>\u2212<\/jats:sup>, 28:7, <jats:italic toggle=\"yes\">P<\/jats:italic>=1), constitutional symptoms (RD<jats:sup>+<\/jats:sup>, 25% vs. RD<jats:sup>\u2212<\/jats:sup>, 9%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.096), multiple enlarged lymph nodes (RD<jats:sup>+<\/jats:sup>, 45% vs. RD<jats:sup>\u2212<\/jats:sup>, 26%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.143), good response to therapy (RD<jats:sup>+<\/jats:sup>, 94% vs. RD<jats:sup>\u2212<\/jats:sup>, 94%, <jats:italic toggle=\"yes\">P<\/jats:italic>=1); higher serum IgG4 levels (&gt;280\u00a0mg\/dL, RD<jats:sup>+<\/jats:sup>, 75% vs. RD<jats:sup>\u2212<\/jats:sup>, 51%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.086), anemia (RD<jats:sup>+<\/jats:sup>, 45% vs. RD<jats:sup>\u2212<\/jats:sup>, 43%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.877), leukopenia (RD<jats:sup>+<\/jats:sup>, 0% vs. RD<jats:sup>\u2212<\/jats:sup>, 3%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.446), thrombocytopenia (RD<jats:sup>+<\/jats:sup>, 10% vs. RD<jats:sup>\u2212<\/jats:sup>, 6%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.556), positivity for antinuclear antibody (RD<jats:sup>+<\/jats:sup>, 24% vs. RD<jats:sup>\u2212<\/jats:sup>, 29%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.688), elevated serum levels of lactate dehydrogenase (&gt;225\u00a0U\/L, RD<jats:sup>+<\/jats:sup>, 0% vs. RD<jats:sup>\u2212<\/jats:sup>, 20%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.064), elevated serum IgE level (&gt;100\u00a0IU\/mL, RD<jats:sup>+<\/jats:sup>, 75% vs. RD<jats:sup>\u2212<\/jats:sup>, 92%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.238), and hypergammaglobulinemia (RD<jats:sup>+<\/jats:sup>, 90% vs. RD<jats:sup>\u2212<\/jats:sup>, 86%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.754). There were also no differences in morphologic patterns (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.466), IgG4<jats:sup>+<\/jats:sup> cell location (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.104), eosinophil counts (RD<jats:sup>+<\/jats:sup>, 10.3\u00b111.3 vs. RD<jats:sup>\u2212<\/jats:sup>, 13.4\u00b117.5, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.496), Epstein-Barr virus positivity (RD<jats:sup>+<\/jats:sup>, 35% vs. RD<jats:sup>\u2212<\/jats:sup>, 60%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.074), and Epstein-Barr virus\u2013positive cell location (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.351). Our findings suggest that there are minimal differences between stringently defined IgG4-RD lymphadenopathy with versus without other manifestations of IgG4-RD. These findings also suggest the existence of IgG4-RD lymphadenopathy as the sole presentation of IgG4-RD.<\/jats:p>","DOI":"10.1097\/pas.0000000000002007","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:48:52Z","timestamp":1675374532000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Lymph Nodes With Increased IgG4-positive Plasma Cells and Patterns Suspicious for IgG4-related Disease"],"prefix":"10.1097","volume":"47","author":[{"given":"Ying-Ren","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology, National Cheng Kung University Hospital, Dou-Liou Branch, College of Medicine, National Cheng Kung University, Yunlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Taiwan University Hospital, College of Medicine, National Taiwan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Ching","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, China Medical University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ling","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Lin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Tai","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Pathology, Taipei Tzu-Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kung-Chao","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan"},{"name":"Department of Pathology, College of Medicine, Kaohsiung Medical University"},{"name":"Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000001076","article-title":"A newly recognized histologic pattern of IgG4-related lymphadenopathy: expanding the morphologic spectrum","volume":"42","author":"Chen","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2012.07.001","article-title":"Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity","volume":"29","author":"Cheuk","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","article-title":"IgG4-related disease: historical overview and pathology of hematological disorders","volume":"60","author":"Sato","year":"2010","journal-title":"Pathol Int"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAS.0000000000001579","article-title":"IgG4-related lymphadenopathy: a comparative study of 41 cases reveals distinctive histopathologic features","volume":"45","author":"Bledsoe","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e318157c068","article-title":"Lymphadenopathy of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman\u2019s disease","volume":"22","author":"Sato","year":"2009","journal-title":"Mod Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.path.2015.09.005","article-title":"Immunoglobulin G4-related lymphadenopathy","volume":"9","author":"Bookhout","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/PAS.0000000000000716","article-title":"Polyclonality in sclerosing angiomatoid nodular transformation of the spleen","volume":"40","author":"Chang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3109\/10428194.2013.861068","article-title":"Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas","volume":"55","author":"Chen","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/10428191003660631","article-title":"BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan","volume":"51","author":"Chen","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"e3785","DOI":"10.1097\/MD.0000000000003785","article-title":"Diagnostic value of serum IgG4 for IgG4-related disease: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Hao","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/PAS.0000000000000206","article-title":"Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease","volume":"38","author":"Takeuchi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10266-018-0377-y","article-title":"Pathogenesis of IgG4-related disease: a critical review","volume":"107","author":"Maehara","year":"2019","journal-title":"Odontology"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2019.01.008","article-title":"IL-10(+) T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease","volume":"207","author":"Ito","year":"2019","journal-title":"Immunol Lett"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00428-021-03187-2","article-title":"Regional disturbance of the distribution of T regulatory cells and T helper cells associated with irregular-shaped germinal centers in immunoglobulin G4-related sialadenitis","volume":"479","author":"Kasashima","year":"2021","journal-title":"Virchows Arch"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/rheumatology\/keab360","article-title":"The role of PD-1\/PD-Ls in the pathogenesis of IgG4-related disease","volume":"61","author":"Zhang","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/BOR.0000000000000686","article-title":"Immune mechanisms of fibrosis and inflammation in IgG4-related disease","volume":"32","author":"Pillai","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.42052","article-title":"Contribution of interleukin-4-induced epithelial cell senescence to glandular fibrosis in IgG4-related sialadenitis","volume":"74","author":"Min","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"eaaq0997","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2021.10.009","article-title":"Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection","volume":"76","author":"Herta","year":"2022","journal-title":"J Hepatol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semdp.2017.11.006","article-title":"Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis","volume":"35","author":"Wick","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1309\/AJCPX6VF6BGZVJGE","article-title":"Abundance of IgG4+ plasma cells in isolated reactive lymphadenopathy is no indication of IgG4-related disease","volume":"142","author":"Martinez","year":"2014","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:01:12Z","timestamp":1749416472000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002007"}},"subtitle":["Can Lymph Nodes Be the Only Site of Disease?"],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002007","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,13]]}}}